In a single centre prospective trial, Zhou J et al. [1] examined the therapeutic benefit of performing an extended pelvic lymph node dissection (ePLND) at radical prostatectomy (RP) by randomising 100 ...
Pelvic lymph node dissection (PLND) remains the most accurate method for staging prostate cancer, yet the adequacy of nodal yield and the absence of standardized specimen processing remain unresolved.
According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...
Fifteen-year outcomes of external radiation with or without 6 months of neoadjuvant deprivation therapy for intermediate risk prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Short-course (3-month) enzalutamide monotherapy in biochemically recurrent prostate cancer (BCR): Preliminary prostate specific membrane antigen tumor volume (PSMA-TV) data. Anatomical location of ...
When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results